Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for atherogenesis

Journal of Experimental Medicine

Volumn 195, Issue 2, 2002, Pages 245-257

  Gerdes, Norbert ^a   Sukhova, Galina K ^a   Libby, Peter ^a   Reynolds, Rebecca S ^a   Young, James L ^a   Schönbeck, Uwe ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; Cytokines; IL 18 IL 18R; Inflammation; Interferon

Indexed keywords

CELL RECEPTOR; COLLAGENASE 3; GAMMA INTERFERON; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MONONUCLEAR PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ARTERIOSCLEROSIS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; MACROPHAGES; METALLOENDOPEPTIDASES; MUSCLE, SMOOTH, VASCULAR; PARACRINE COMMUNICATION; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-18;

EID: 0037148510     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011022     Document Type: Article

References (52)

1. Inflammatory and immune mechanisms in atherogenesis
2. Atherosclerosis-an inflammatory disease
3. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines
4. IFN-γ potentiates atherosclerosis in ApoE knock-out mice
5. Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts
6. Interferon-γ elicits arteriosclerosis in the absence of leukocytes
7. -/- mice
8. Response of resting human peripheral blood natural killer cells to interleukin 2
9. Role of interferon-γ in immune cell regulation
10. Interferon-γ gene expression in human B-cell lines: Induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation
11. Expression of tumour necrosis factor-α, -β and interferon-γ genes within human neuroglial tumour cells and brain specimens
12. Interferon γ upregulates its own gene expression in mouse peritoneal macrophages
13. γ interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis
14. Cloning of a new cytokine that induces IFN-γ production by T cells
15. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein
16. + human blood mononuclear cells
17. Interleukin-18 (interferon-γ-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-γ to inhibit osteoclast formation
18. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses
19. Production of IL-18 (IFN-γ-inducing factor) messenger RNA and functional protein by murine keratinocytes
20. Interleukin-18 regulates both th1 and th2 responses
21. Interleukin-18
22. Activation of interferon-γ inducing factor mediated by interleukin-1beta converting enzyme
23. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production
24. Interferon-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-γ production
25. Defective NK cell activity and Th1 response in IL-18-deficient mice
26. Interleukin-18 regulation of interferon γ production and cell proliferation as shown in interleukin-1β-converting enzyme (caspase-1)-deficient mice
27. Immune interferon inhibits proliferation and induces 2;-5′-Oligoadenylate synthetase gene expression in human vascular smooth muscle cells
28. γ interferon regulates vascular smooth muscle proliferation and Ia expression in vivo and in vitro
29. Interleukin-18/interferon-γ-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells
30. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells
31. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family
32. Purification and characterization of the human interleukin-18 receptor
33. Cloning of a novel receptor subunit, AcPL, required for IL-18 signaling
34. Generation of IL-18 receptor-deficient mice: Evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor
35. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis
36. A proinflammatory role for IL-18 in rheumatoid arthritis
37. Interleukin 18: A pleiotropic participant in chronic inflammation
38. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques
39. Expression of stromelysin-3 in atherosclerotic lesions: Regulation via CD40-CD40 ligand signaling in vitro and in vivo
40. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1β-converting enzyme
41. The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1β-converting enzyme (caspase-1) activity in human vascular smooth muscle cells
42. Cytokines and growth regulatory molecules
43. Interferon-γ inhibits both proliferation and expression of differentiation-specific α-smooth muscle actin in arterial smooth muscle cells
44. Production of cytokines by vascular wall cells: An update and implications for atherogenesis
45. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-γ knockout recipients
46. Immunohistochemical detection of interferon-γ. Fake or fact?
47. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability
48. Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1β are differentially regulated in human blood mononuclear cells and mouse spleen cells
49. Expression and responsiveness of human interleukin-18 receptor (IL-18R) on hematopoietic cell lines
50. Interleukin-18/interleukin-18 binding protein signaling modulaes atherosclerotic lesion development and stability
51. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB
52. Interleukin-10 blocks atherosclerotic events in vitro and in vivo